Dr Reddy's gets EIR for Vizag plant, but inspection not closed Ruby Khatun Khatun22 Nov 2017 11:06 AM ISTNew Delhi: Dr. Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator for its formulation...
Dr Reddys receives EIR for Srikakulam plant, shares soar Ruby Khatun Khatun22 Sept 2017 10:29 AM ISTNew Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the...
Dr Reddys Vizag unit gets 6 observations by German regulator Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTNew Delhi: Dr Reddy's Laboratories (DRL) said the German drug regulator has concluded the audit of its Visakhapatnam formulations facility with six...
Dr Reddys launches antidepressant, muscle relaxant tablets in US Ruby Khatun Khatun7 Sept 2017 11:19 AM ISTNew Delhi: Dr. Reddy's Laboratories on Wednesday said it has launched Bupropion Hydrochloride extended-release tablets used in treating a major...
Dr Reddys out-licenses steroid DFD-06 to Encore Dermatology Ruby Khatun Khatun24 Aug 2017 11:00 AM ISTNew Delhi: Drug major Dr Reddy's Laboratories on Tuesday said it has out-licensed the future development, manufacturing and commercialisation rights...
